Data month 2026-08
NeuroKaireneurokaire.comUsing biological response to aid depression medication selection
According to AlphaMoat, in 2026-08 NeuroKaire (neurokaire.com) received 2,580 monthly visits (-13.1% MoM) — ranked #14,519 of 17,407 AI websites with traffic data, and #2,548 of 3,173 in Industry Services; its largest market is United States (72.8% of visits).
Monthly Visits · 2026-08
2.6K-13.1%
Overall Rank (17,407)
#14,519
Industry Services Rank (3,173)
#2,548
Top Market
United States72.8%
What is NeuroKaire
Product Overview
NeuroKaire (formerly GenetikaPlus) is dedicated to replacing trial-and-error antidepressant treatment with biological evidence, helping doctors and patients obtain quantifiable biological grounds for medication choice at an earlier stage.
Key Features4 items
- 01Neuroscience and cellular modeling with biometrics for drug response
- 02Focus on depression care
- 03Extending biological-response assessment to more areas
- 04Guided by scientific validation and clinical need
12-Month Traffic Trend
Hover for monthly values
Latest 2.6KMoM-13.1%
2026-06
5.4K
—
2026-07
3.0K
-44.7%
2026-08
2.6K
-13.1%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
1,87772.8%
Israel
70327.2%
Popular in Industry Services
Click for details, or "+ Compare" to compare with NeuroKaire
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.